Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer.
about
The genetic signatures of noncoding RNAsIdentification of novel endogenous antisense transcripts by DNA microarray analysis targeting complementary strand of annotated genes.Analysis of antisense expression by whole genome tiling microarrays and siRNAs suggests mis-annotation of Arabidopsis orphan protein-coding genes.MeDIP-seq and nCpG analyses illuminate sexually dimorphic methylation of gonadal development genes with high historic methylation in turtle hatchlings with temperature-dependent sex determinationLong Noncoding RNAs as Biomarkers in Cancer.Refining transcriptional programs in kidney development by integration of deep RNA-sequencing and array-based spatial profiling.Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB.Expression and prognostic impact of lncRNAs in acute myeloid leukemia.The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cellEstrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cellsThe landscape of antisense gene expression in human cancers.Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition.WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma.Long non-coding RNA in cancer.Long non-coding RNAs in haematological malignancies.Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels.Non-coding RNAs as direct and indirect modulators of epigenetic regulation.Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma.Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations.Regulatory variations in the era of next-generation sequencing: implications for clinical molecular diagnostics.Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena.The AS-RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation.Global network random walk for predicting potential human lncRNA-disease associations.Long noncoding RNAs in hematopoietic malignancies.Post-transcriptional Regulation of Genes Related to Biological Behaviors of Gastric Cancer by Long Noncoding RNAs and MicroRNAs.Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.Analysis of long non-coding RNA (lncRNA) expression in hepatitis B patients.Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution.Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations.Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network
P2860
Q21092463-12E974CF-B054-4FEB-B3CA-298B65EC9085Q33495737-3D937D4C-1BCD-4455-9D6F-B11921B77315Q33592928-C1B753D9-7CEF-4FD9-91F0-D87361375A39Q33709275-09F3D551-B57A-4762-B219-B9AF83950A23Q33786847-A04212B9-FF61-4DEA-9688-ED42C01F8B87Q34010252-92DB7757-9802-4A64-801E-E1275D17E4B9Q34671934-800CB172-ABE8-472D-86B3-F39923CC7261Q34831106-54CA9460-7359-4DD7-AA28-FA2A0BDB265BQ35010973-D2A988B4-A6FF-4343-86DB-8E915C70EA16Q35020435-1D5B09C3-B0AF-4DB9-9475-4C419A0CE58FQ35203507-02AB5DEB-0B8C-414A-9D47-05405E087C74Q35793492-4C608118-A27E-41A6-808B-37C31DA4A1C0Q35974177-DA678400-79FE-4718-A6CE-60DF185BD0D4Q36159699-56181465-F3AF-41F4-8F3F-BFFA02B30E9DQ36619041-F2D6E8D9-6D70-4BC1-A540-E1B33C75B504Q36790436-1BAE3F64-6F96-45B1-99D9-C28AAA106A66Q37139037-7DEC8BCB-07EC-4390-8895-0A2648E48340Q37510844-1C9742A8-598A-4ADE-9F12-FA6B746D2D3BQ37591537-7E35BF64-C676-45DC-B117-E2E702980F21Q37681202-0CCA88BA-08E0-4120-9117-E4746F270429Q37707041-8CE5BCC6-CC6C-4B21-8FD0-EC354F770B07Q37995121-F8465D38-BD13-4691-BCBE-2A02E3857956Q38388111-9F24862D-B821-46A0-82BE-B977979FBF55Q38645336-D120AAD9-4A1B-4319-9416-4DC9DDF8CAE5Q38775132-05E79FB0-908B-479A-8D89-27C18B980A7AQ42367781-C4E4653A-72BF-4999-842B-663DCEA5D744Q46191604-0ACDC9E7-D1C8-4885-B459-5461EF674511Q47149869-A1E38762-9F15-4C11-8EAB-F9D29D21C1EFQ50114394-53FAE4C7-1EC8-490F-A795-47D21306BE73Q52691452-43292FFD-6DDD-4198-8033-F77120F73DD9Q53636125-F8A0835C-44AA-4E7A-A451-AE5C28CCEC50Q54214351-7373ED52-D14F-474A-A00E-CA33E146564BQ58742926-F1BBAE8A-730C-427A-BCC3-AB004E806153
P2860
Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Alternately spliced WT1 antise ...... nd splicing defects in cancer.
@en
type
label
Alternately spliced WT1 antise ...... nd splicing defects in cancer.
@en
prefLabel
Alternately spliced WT1 antise ...... nd splicing defects in cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Alternately spliced WT1 antise ...... nd splicing defects in cancer.
@en
P2093
Anne L Hancock
Ashreena Salpekar
Karim T A Malik
Keith W Brown
Linda King-Underwood
Sally Malik
P2860
P304
P356
10.1261/RNA.562907
P407
P577
2007-10-16T00:00:00Z